Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 26901429)

  • 1. One-pot synthesis of pH-responsive hybrid nanogel particles for the intracellular delivery of small interfering RNA.
    Khaled SZ; Cevenini A; Yazdi IK; Parodi A; Evangelopoulos M; Corbo C; Scaria S; Hu Y; Haddix SG; Corradetti B; Salvatore F; Tasciotti E
    Biomaterials; 2016 May; 87():57-68. PubMed ID: 26901429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-targeting and pH/redox-responsive multi-layered nanocomplexes for smart co-delivery of doxorubicin and siRNA.
    Han L; Tang C; Yin C
    Biomaterials; 2015 Aug; 60():42-52. PubMed ID: 25982552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction/photo dual-responsive polymeric prodrug nanoparticles for programmed siRNA and doxorubicin delivery.
    Wu M; Li J; Lin X; Wei Z; Zhang D; Zhao B; Liu X; Liu J
    Biomater Sci; 2018 May; 6(6):1457-1468. PubMed ID: 29770812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor acidity-sensitive linkage-bridged block copolymer for therapeutic siRNA delivery.
    Xu CF; Zhang HB; Sun CY; Liu Y; Shen S; Yang XZ; Zhu YH; Wang J
    Biomaterials; 2016 May; 88():48-59. PubMed ID: 26945455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination antitumor immunotherapy with VEGF and PIGF siRNA via systemic delivery of multi-functionalized nanoparticles to tumor-associated macrophages and breast cancer cells.
    Song Y; Tang C; Yin C
    Biomaterials; 2018 Dec; 185():117-132. PubMed ID: 30241030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery.
    Prabhakar N; Zhang J; Desai D; Casals E; Gulin-Sarfraz T; Näreoja T; Westermarck J; Rosenholm JM
    Int J Nanomedicine; 2016; 11():6591-6608. PubMed ID: 27994460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-Delivery of Doxorubicin and Survivin shRNA-Expressing Plasmid Via Microenvironment-Responsive Dendritic Mesoporous Silica Nanoparticles for Synergistic Cancer Therapy.
    Li Z; Zhang L; Tang C; Yin C
    Pharm Res; 2017 Dec; 34(12):2829-2841. PubMed ID: 28948461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer.
    Zhuang J; Chen S; Hu Y; Yang F; Huo Q; Xie N
    Int J Nanomedicine; 2021; 16():1961-1976. PubMed ID: 33727809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultra-pH-Responsive and Tumor-Penetrating Nanoplatform for Targeted siRNA Delivery with Robust Anti-Cancer Efficacy.
    Xu X; Wu J; Liu Y; Yu M; Zhao L; Zhu X; Bhasin S; Li Q; Ha E; Shi J; Farokhzad OC
    Angew Chem Int Ed Engl; 2016 Jun; 55(25):7091-7094. PubMed ID: 27140428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review of pH-Responsive Organic-Inorganic Hybrid Nanoparticles for RNAi-Based Therapeutics.
    Wang L; Yan Y
    Macromol Biosci; 2021 Sep; 21(9):e2100183. PubMed ID: 34160896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precision combination therapy for triple negative breast cancer via biomimetic polydopamine polymer core-shell nanostructures.
    Ding Y; Su S; Zhang R; Shao L; Zhang Y; Wang B; Li Y; Chen L; Yu Q; Wu Y; Nie G
    Biomaterials; 2017 Jan; 113():243-252. PubMed ID: 27829203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular cleavable poly(2-dimethylaminoethyl methacrylate) functionalized mesoporous silica nanoparticles for efficient siRNA delivery in vitro and in vivo.
    Lin D; Cheng Q; Jiang Q; Huang Y; Yang Z; Han S; Zhao Y; Guo S; Liang Z; Dong A
    Nanoscale; 2013 May; 5(10):4291-301. PubMed ID: 23552843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA.
    Yang XZ; Dou S; Wang YC; Long HY; Xiong MH; Mao CQ; Yao YD; Wang J
    ACS Nano; 2012 Jun; 6(6):4955-65. PubMed ID: 22646867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of siRNA pre-Exposure on Subsequent Response to siRNA Therapy.
    Aliabadi HM; Mahdipoor P; Kucharsky C; Chan N; Uludağ H
    Pharm Res; 2015 Dec; 32(12):3813-26. PubMed ID: 26129766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice.
    Jadidi-Niaragh F; Atyabi F; Rastegari A; Kheshtchin N; Arab S; Hassannia H; Ajami M; Mirsanei Z; Habibi S; Masoumi F; Noorbakhsh F; Shokri F; Hadjati J
    J Control Release; 2017 Jan; 246():46-59. PubMed ID: 27993599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversibly Stabilized Polycation Nanoparticles for Combination Treatment of Early- and Late-Stage Metastatic Breast Cancer.
    Chen G; Wang Y; Wu P; Zhou Y; Yu F; Zhu C; Li Z; Hang Y; Wang K; Li J; Sun M; Oupicky D
    ACS Nano; 2018 Jul; 12(7):6620-6636. PubMed ID: 29985577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endosomolytic and Tumor-Penetrating Mesoporous Silica Nanoparticles for siRNA/miRNA Combination Cancer Therapy.
    Wang Y; Xie Y; Kilchrist KV; Li J; Duvall CL; Oupický D
    ACS Appl Mater Interfaces; 2020 Jan; 12(4):4308-4322. PubMed ID: 31939276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chitosan nanoparticle-delivered siRNA reduces
    Yu S; Chen Y; Li X; Gao Z; Liu G
    Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28446538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucose-linked sub-50-nm unimer polyion complex-assembled gold nanoparticles for targeted siRNA delivery to glucose transporter 1-overexpressing breast cancer stem-like cells.
    Yi Y; Kim HJ; Zheng M; Mi P; Naito M; Kim BS; Min HS; Hayashi K; Perche F; Toh K; Liu X; Mochida Y; Kinoh H; Cabral H; Miyata K; Kataoka K
    J Control Release; 2019 Feb; 295():268-277. PubMed ID: 30639386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lyophilization and stability of antibody-conjugated mesoporous silica nanoparticle with cationic polymer and PEG for siRNA delivery.
    Ngamcherdtrakul W; Sangvanich T; Reda M; Gu S; Bejan D; Yantasee W
    Int J Nanomedicine; 2018; 13():4015-4027. PubMed ID: 30022824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.